Join the Diabetes, Type 2 group to help and get support from people like you.
Diabetes, Type 2 News (Page 7)
Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2
Yogurt Makers Can Make Limited Claims About Type 2 Diabetes Prevention: FDA
MONDAY, March 4, 2024 – Yogurt makers can now make limited claims about the food's power to help prevent type 2 diabetes, the U.S. Food and Drug Administration says. In a statement released Friday,...
In Type 2 Diabetes, Glycemic Control Superior After Bariatric Surgery
THURSDAY, Feb. 29, 2024 – For patients with type 2 diabetes, glycemic control is superior with bariatric surgery versus medical/lifestyle intervention after seven to 12 years of follow-up, according...
FDA Warns of Smartwatches That Claim to Measure Glucose Levels
THURSDAY, Feb. 22, 2024 – The U.S. Food and Drug Administration has issued an advisory regarding smartwatches and smart rings that claim to track blood glucose levels. "Sellers of these smartwatches...
Don't Use Smartwatches That Claim to Measure Blood Sugar, FDA Warns
THURSDAY, Feb. 22, 2024 – Some Americans living with diabetes are using smartwatches and smart rings that claim to be able to track their blood sugar. However, such claims from any device that does...
Out-of-Pocket Costs Are Tough on Americans With Diabetes
WEDNESDAY, Feb. 21, 2024 – People with diabetes have to spend a ton of money to stay healthy, a new study reports. Total and out-of-pocket costs for diabetics run hundreds to thousands of dollars...
Position Statement Addresses Optimal Management of Diabetes
WEDNESDAY, Feb. 21, 2024 – In an Endocrine Society position statement published online Feb. 21 in the Journal of Clinical Endocrinology and Metabolism, guidelines are presented to help health care...
Type 2 Diabetes Remission Maintained After RYGB Despite Weight Regain
TUESDAY, Feb. 13, 2024 – Despite weight regain (WR), type 2 diabetes mellitus (T2DM) remission rates are generally maintained after Roux-en-Y gastric bypass (RYGB), according to research published...
Sodium-Glucose Cotransporter 2 Inhibitors Tied to Lower Kidney Stone Risk
THURSDAY, Feb. 8, 2024 – For adults with type 2 diabetes, initiation of sodium-glucose cotransporter 2 inhibitors (SGLT2is) may lower the risk for nephrolithiasis, according to a study published...
Exercise Intensity, Duration Can Affect CKD Risk in Obesity, Type 2 Diabetes
WEDNESDAY, Feb. 7, 2024 – For adults with overweight/obesity and type 2 diabetes (T2D), longer duration of moderate-to-vigorous physical activity (MVPA) and increases in MVPA are associated with a...
Pandemic Tied to Worsening of Diabetes Outcomes
THURSDAY, Feb. 1, 2024 – COVID-19 pandemic disruptions had a fairly negative impact on diabetes outcomes, according to a study published in the February issue of The Lancet Diabetes & Endocrinology. ...
Discontinuation Notice: Levemir Products to be Discontinued from January 2024
November 8, 2024 – Due to global manufacturing constraints, formulary losses impacting patient access, and the availability of alternative options, Novo Nordisk will be discontinuing Levemir® in the ...
Diabetes Risk in Overweight, Obese Teens Varies Substantially by Baseline HbA1c
TUESDAY, Jan. 30, 2024 – Five-year diabetes risk among teens with overweight or obesity varies substantially by baseline HbA1c levels, according to a study published online Jan. 17 in JAMA Network ...
GLP1 Agonists Reduce Major Adverse Liver Outcomes in Chronic Liver Disease
MONDAY, Jan. 29, 2024 – For patients with chronic liver disease and type 2 diabetes, glucagon-like peptide-1 receptor (GLP1) agonists may result in a lower risk for major adverse liver outcomes...
Health Disparities in Cardiometabolic Disease Seen Within Racial Subgroups
THURSDAY, Jan. 25, 2024 – Health disparities are seen in the prevalence of cardiometabolic diseases by disaggregated racial and ethnic subgroups, according to research published in the Jan. 25 issue...
Risk for CKD, CVD Lower for Adults With Evidence of Type 2 Diabetes Remission
FRIDAY, Jan. 26, 2024 – Individuals with evidence of remission of type 2 diabetes have a considerably reduced risk for chronic kidney disease (CKD) and cardiovascular disease (CVD), according to a...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Related drug support groups
metformin, Ozempic, Victoza, Lantus, Mounjaro, Trulicity, glipizide, semaglutide, Rybelsus, view more... Lantus Solostar, Humalog, Farxiga, Novolog, Jardiance, Janumet, insulin glargine, Januvia, insulin lispro, Bydureon, Tresiba, Levemir, liraglutide, Invokana, Glucophage, Humulin N, insulin degludec